Advertisement

U.S. Markets closed

S&P Futures
5,763.00
+1.00(+0.02%)
Dow Futures
42,440.00
-3.00(-0.01%)
Nasdaq Futures
20,036.00
+7.75(+0.04%)
Russell 2000 Futures
2,258.70
+6.10(+0.27%)
Crude Oil
70.99
-0.01(-0.01%)
Gold
2,644.50
-1.70(-0.06%)

Nuvalent, Inc. (NUVL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

108.00

+4.75

(+4.60%)

At close: 04:00PM EDT

107.89

-0.11

(-0.10%)

After hours:

06:58PM EDT

Trade prices are not sourced from all markets

All

Zacks
Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRNA Down on Updates
Gilead Sciences and Nuvalent are in the spotlight following positive updates on key candidates.
PR Newswire
Nuvalent Announces Closing of Upsized Public Offering of Common Stock
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the closing of its previously announced upsized underwritten public offering of 5,750,000 shares of Class A common stock, which includes 750,000 shares of Class A common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares, at a price to the public of $100
Zacks
Nuvalent Stock Moves Up 20% in a Week: What's Driving the Rally?
The upside comes after NUVL reported encouraging data on two experimental lung cancer therapies.